| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5170665
Max Phase: Preclinical
Molecular Formula: C26H32N2O9S
Molecular Weight: 548.61
Associated Items:
Representations
Canonical SMILES: COc1ccc(S(=O)(=O)N(Cc2nc(-c3cc(OC)c(OC)c(OC)c3)oc2C)[C@@H](C(=O)O)C(C)C)cc1
Standard InChI: InChI=1S/C26H32N2O9S/c1-15(2)23(26(29)30)28(38(31,32)19-10-8-18(33-4)9-11-19)14-20-16(3)37-25(27-20)17-12-21(34-5)24(36-7)22(13-17)35-6/h8-13,15,23H,14H2,1-7H3,(H,29,30)/t23-/m1/s1
Standard InChI Key: JTZABEZHANOPHJ-HSZRJFAPSA-N
Associated Targets(Human)
Programmed cell death protein 4 60 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 548.61 | Molecular Weight (Monoisotopic): 548.1829 | AlogP: 3.98 | #Rotatable Bonds: 12 |
| Polar Surface Area: 137.63 | Molecular Species: ACID | HBA: 9 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 3.50 | CX Basic pKa: 0.49 | CX LogP: 3.30 | CX LogD: -0.07 |
| Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.35 | Np Likeness Score: -0.73 |
References
| 1. Peng T, He Y, Wang T, Yu J, Ma X, Zhou Z, Sheng Y, Li L, Peng H, Li S, Zou J, Yuan Y, Zhao Y, Shi H, Li F, Liu W, Hu K, Lu X, Lu X, Zhang G, Wang F.. (2022) Discovery of a Novel Small-Molecule Inhibitor Disrupting TRBP-Dicer Interaction against Hepatocellular Carcinoma via the Modulation of microRNA Biogenesis., 65 (16.0): [PMID:35695407] [10.1021/acs.jmedchem.2c00189] |
Source
Source(1):